UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that inhibiting the enzyme CARM1 (also called PRMT4) dramatically slows acute myeloid leukemia (AML) progression but does not affect normal blood production.

Full Story

Related posts

UCF Alumni Developing Self-Heating Blankets to Save Babies

Compared to existing warming blankets that reflect body heat, this blanket generates heat on its…

NSU: Novel Approach Studies Whale Shark Ages the Best Way – While They Are Swimming

New study reveals world’s largest fish is larger and lives longer than previously thought. Full…

FIU: Long-term changes chart future of ecosystems

Long-term research is important in restoring and managing the Florida Everglades and other vulnerable ecosystems,…